Products:Neuroscience >> Neurology process >> Neurodegenerative disease >> Parkinson's disease >> Synuclein
|
ab48842 |
|
|
ab48853 |
|
|
ab51173 |
|
|
ab51176 |
|
|
ab51186 |
|
|
ab123758 |
|
|
ab125777 |
|
|
ab125808 |
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Publishing research using ab6176? Please let us know so that we can cite the reference in this datasheet
ab6176 has been referenced in 6 publications.
Publishing research using ab6176? Please let us know so that we can cite the reference in this datasheet
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
ICC/IF image of ab6176 stained HeLa cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab6176, 1µg/ml) overnight at +4ºC. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
1
Call 01223 696 000 or contact us